BiomX Inc.

PHGE

BiomX Inc.

PHGE

Insider Sentiment (TTM):

Last Purchase:2023-05-22Last Sale:2026-03-17Shares Purchased (TTM):0Shares Sold (TTM):900,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:298,831Shares Outstanding:2,603,807Institutional Ownership Pct.:11.48%

Earnings Market Reaction:

Filing Date:2026-08-19Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Private Placement	-	-	-	-	-	-	-	-	25	-	-	-
Assets
Cash And Cash Equivalents At Carrying Value	0	1	4	7	14	20	17	24	32	43	15	22
Assets Current
Assets Current	2	3	6	9	17	24	21	28	35	47	18	25
Restricted Cash Current	-	-	1	1	1	1	1	1	1	1	1	1
Other Assets Current	2	2	0	1	2	2	3	4	2	3	2	2
Non Current Assets
Other Assets Noncurrent	-	-	-	-	-	-	-	0	0	-	-	-
Restricted Cash Noncurrent	-	-	-	0	0	0	0	-	-	-	-	-
Assets Noncurrent
Assets Noncurrent	-	-	0	17	21	22	23	32	34	35	7	8
Operating Lease Right Of Use Asset	-	-	-	2	5	5	5	10	10	11	3	4
Property Plant And Equipment Net	-	-	-	3	4	5	5	7	7	7	4	4
Goodwill	-	-	-	-	-	-	-	-	16	16	-	-
Development In Process	-	-	-	-	-	-	-	15	-	-	-	-
Assets	28	3	6	26	38	46	43	60	69	82	25	33
Liabilities And Stockhold…
Accounts Payable Trade Current	1	1	3	2	2	2	2	3	3	4	1	1
Long Term Debt And Capital Lease Obligations Curre…	-	-	-	-	-	-	-	-	-	-	-	1
Liabilities Current
Liabilities Current	10	2	6	5	6	7	8	9	7	11	11	13
Other Notes Payable Current	1	1	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Current	0	-	1	1	1	1	1	1	1	1	1	-
Accounts Payable Other Current	1	0	2	2	3	4	5	5	3	6	3	6
Debt And Capital Lease Obligations	-	-	-	-	-	-	-	-	-	-	-	6
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	6	-
Non Current Liabilities
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	-	2	2	2
Long Term Debt Noncurrent	-	-	-	-	-	-	-	-	-	-	5	7
Liabilities Noncurrent
Liabilities Noncurrent	0	2	1	10	13	14	11	13	34	48	11	12
Operating Lease Liability Noncurrent	-	-	-	5	8	8	8	9	9	9	3	3
Other Liabilities Noncurrent	-	-	-	0	0	0	0	0	0	0	0	0
Warrants And Rights Outstanding	0	2	1	5	4	6	2	4	25	-	-	-
Redeemable Convertible Pr…
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	32	-	-
Liabilities	11	4	-	-	-	-	-	-	-	-	-	-
Preferred Stock Value	7	19	19	19	19	19	19	19	32	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Receivable From Shareholders Or Affiliates For Iss…	-0	-3	-	-	-	-	-	-	-	-	-	-
Stockholders Equity	11	-1	-1	10	19	24	24	38	27	-10	3	8
Additional Paid In Capital	244	220	197	195	195	194	186	185	171	171	166	166
Retained Earnings Accumulated Deficit	-240	-236	-217	-204	-194	-188	-181	-166	-176	-180	-163	-157
Liabilities And Stockholders Equity	28	3	6	26	38	46	43	60	69	82	25	33
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	-	-	-	0	-	-
Temporary Equity Shares Authorized	-	-	-	-	-	-	-	-	-	1	-	-
Temporary Equity Shares Issued	-	-	-	-	-	-	-	-	-	0	-	-
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	0	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	-	0	0
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	-	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	-	-	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	-	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	750	750	750	750	750	750	750	750	120	120	120	120
Common Stock Shares Issued	13	7	2	27	26	25	1	18	7	6	5	5
Shares Outstanding	13	7	2	27	26	25	1	18	7	6	5	5

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-10.22%	-61.14%	-71.19%	-	-	-	-	-	-	-	-	-
2025	-16.84%	-21.99%	-29.61%	4.23%	4.44%	-0.40%	-27.63%	-70.04%	-19.93%	18.36%	-44.74%	-88.01%
2024	-0.58%	-0.58%	-44.44%	-35.33%	-50.11%	-60.43%	-18.67%	3.33%	-2.80%	-7.69%	-7.69%	-30.09%
2023	-	-	-	-	-	-	-26.49%	-29.09%	-42.86%	-7.89%	-10.53%	-12.37%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.24	1.24	0.87	1.70	2.66	3.35	2.48	3.17	4.80	4.40	1.58	1.98
Quick Ratio	0.24	1.24	0.87	1.70	2.66	3.35	2.48	3.17	4.80	4.40	1.58	1.98
Working Capital	-7.76M	596.00K	-804.00K	3.64M	10.37M	16.51M	12.25M	19.37M	27.78M	36.39M	6.46M	12.52M
Leverage & Debt
Debt to Equity	0.97	-4.69	-5.44	1.50	0.99	0.86	0.79	0.58	1.50	-6.15	7.12	3.05
Interest Coverage TTM	148.59	169.11	2,073.30	2,020.50	2,160.10	1,624.79	51.00	23.85	15.11	9.64	10.54	10.47
Debt Ratio	0.37	1.27	1.23	0.60	0.50	0.46	0.44	0.37	0.60	0.72	0.88	0.75
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	4.41	-	22.19	1.19	0.59	0.35	23.39	0.53	2.44	5.96	5.10	4.38
Free Cash Flow Per Share TTM	-2.15	-9.16	-16.18	-0.62	-12.45	-28.26	-53.90	-2.30	-5.08	-4.54	-4.16	-3.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	145.00%	491.64%	104.20%	329.35%	-29.28%	-78.30%	-32.26%	-67.23%	3.20%	40.08%	-7.59%	-19.23%
EPS Growth (1Y)	-60.85%	176.29%	-12.50%	123.79%	199.62%	11.18%	397.54%	-87.87%	-23.79%	-27.76%	-46.25%	-60.13%
Valuation Metrics
P/E TTM	0.08	0.21	0.08	8.38	0.76	1.59	0.55	36.44	16.98	14.34	10.44	15.25
P/B TTM	0.33	-11.09	-2.34	29.87	0.74	0.52	0.40	8.37	16.25	-55.80	88.63	49.69
Market Cap	3.59M	9.77M	3.05M	313.21M	14.09M	12.85M	9.69M	317.18M	445.66M	532.60M	273.08M	405.21M
Enterprise Value	3.24M	8.61M	-1.31M	305.14M	42.78K	-8.38M	-8.28M	292.52M	412.95M	488.48M	268.40M	389.26M
Calculated Values
Free Cash Flow TTM	-22.20M	-23.84M	-26.39M	-19.59M	-20.52M	-34.37M	-37.67M	-37.62M	-35.47M	-28.30M	-21.34M	-22.29M
Net Debt	-347.00K	-1.17M	-4.36M	-8.07M	-14.05M	-21.23M	-17.98M	-24.65M	-32.71M	-44.12M	-4.68M	-15.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-17Sale

Owner: Yeganeh, Reuven

Title: -

Shares: 530,000

Price/Share: $5.00

Value: $2,650,000.00

Shares Owned: -

Relationship: Director,TenPercentOwner

Ownership: Indirect

2026-03-13Sale

Owner: Yeganeh, Reuven

Title: -

Shares: 370,000

Price/Share: $5.00

Value: $1,850,000.00

Shares Owned: -

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-05-15Sale

Owner: Gordon, Carl L, Orbimed I…

Title: -

Shares: 24,344

Price/Share: $0.38

Value: $9,250.72

Shares Owned: 13,773,653

Relationship: TenPercentOwner

Ownership: Indirect

2023-11-29Sale

Owner: Oron, Assaf

Title: Chief Business Officer

Shares: 10,914

Price/Share: $0.36

Value: $3,929.04

Shares Owned: -

Relationship: Officer

Ownership: Direct

2023-05-22Purchase

Owner: Oron, Assaf

Title: Chief Business Officer

Shares: 3,192

Price/Share: $0.27

Value: $861.84

Shares Owned: 10,914

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-17	Yeganeh, Reuven	Director,TenPercentOwner	-	Indirect	Sale	530,000	5.00	$2,650,000.00	0	4
2026-03-13	Yeganeh, Reuven	Director,TenPercentOwner	-	Indirect	Sale	370,000	5.00	$1,850,000.00	0	4
2024-05-15	Gordon, Carl L, Orbimed I…	TenPercentOwner	-	Indirect	Sale	24,344	0.38	$9,250.72	13,773,653	4
2023-11-29	Oron, Assaf	Officer	Chief Business Officer	Direct	Sale	10,914	0.36	$3,929.04	0	4
2023-05-22	Oron, Assaf	Officer	Chief Business Officer	Direct	Purchase	3,192	0.27	$861.84	10,914	4
2023-05-19	Oron, Assaf	Officer	Chief Business Officer	Direct	Purchase	6,521	0.28	$1,825.88	7,722	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

11.48%

Inst. Shares: 298,831

Shares Outstanding: 2,603,807

2025-12-31

18.52%

Inst. Shares: 302,116

Shares Outstanding: 1,631,037

2025-09-30

26.46%

Inst. Shares: 8,308,392

Shares Outstanding: 31,399,552

2025-06-30

34.54%

Inst. Shares: 10,812,914

Shares Outstanding: 31,308,396

2025-03-31

Inst. Shares: 13,274,847

Shares Outstanding: 1,215,953

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	298,831	2,603,807	11.48%
2025-12-31	302,116	1,631,037	18.52%
2025-09-30	8,308,392	31,399,552	26.46%
2025-06-30	10,812,914	31,308,396	34.54%
2025-03-31	13,274,847	1,215,953	-
2024-12-31	9,933,212	698,870	-
2024-09-30	9,029,793	16,366,122	55.17%
2024-06-30	22,999,779	6,980,943	-
2024-03-31	24,507,646	6,229,228	-
2023-12-31	7,980,097	5,133,093	155.46%
2023-09-30	7,307,970	6,058,774	120.62%
2023-06-30	7,458,415	5,155,292	144.67%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

BiomX Inc. (PHGE) — SEC Financial Statements & Analysis

BiomX Inc. (PHGE) is a biological products, (no diagnostic substances) company, incorporated in DE. BiomX Inc. trades on NYSE as: PHGE. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), BiomX Inc. reported a Debt-to-Equity ratio of 0.97x, a Price-to-Book (P/B) ratio of 0.33x (TTM), at a market cap of $3.59M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.97x
P/B TTM: 0.33x
Market Cap: $3.59M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BiomX Inc. in?

BiomX Inc. (PHGE) operates in the Biological Products, (No Diagnostic Substances) industry.

What is PHGE's market cap?

BiomX Inc. (PHGE) has a market capitalization of $3.59M as of 2026-06-30.

What is PHGE's P/E ratio?

BiomX Inc. (PHGE)'s trailing twelve month P/E ratio is 0.08x as of 2026-06-30.

What exchange does PHGE trade on?

BiomX Inc. (PHGE) trades on the NYSE.

Where is BiomX Inc. incorporated?

BiomX Inc. is incorporated in DE.

BiomX Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

BiomX Inc. (PHGE) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

BiomX Inc. (PHGE) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.